Saturday March 20 2010 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
Claudication News and Headlines
Claudication News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Claudication
news alerts
.
Site Map
>
Biotechnology News
>
Health News
> Claudication
.
Surgery: Research results from Erasmus Medical Center, Department of Anesthesiology update knowledge of surgery
NewsRX:
similar ...
ActivBiotics Announces Initiation of Phase II Study in Carotid Atherosclerosis
Canada Newswire Ltd. All Rights Reserved.:
similar ...
ActivBiotics, Inc. Announces Completion of Patient Enrollment in Phase III Clinical Trial in Peripheral Arterial Disease
Canada Newswire Ltd. All Rights Reserved.:
similar ...
Endovasc Announces Completion of Liprostin Manufacturing for Phase IIIa Trial
Business Wire:
similar ...
Studies from Netherlands, Sweden and Denmark advance knowledge in stroke research
Pain & Central Nervous System Week via NewsRx.com:
similar ...
Researchers' findings from Sweden, the United States and Denmark advance stroke research
Pain & Central Nervous System Week via NewsRx.com:
similar ...
Endovasc Announces Agreement with PYRAMID Labs to Manufacture Liprostin for Phase IIIa Trial
Business Wire:
similar ...
ActivBiotics Receives FDA Fast Track Status for Rifalazil in Peripheral Arterial Disease
Canada Newswire Ltd. All Rights Reserved.:
similar ...
Angiogenesis declines without sustained gene expression after VEGF transfer
Angiogenesis Weekly via NewsRx.com:
similar ...
Novel treatment can remedy common cause of disabling leg pain
Angiogenesis Weekly via NewsRx.com:
similar ...
NicOx Reports 2004 Financial Results
Business Wire:
similar ...
Vasogen announces full patient enrolment in its pivotal Phase III trial of Celacade in peripheral arterial disease.
CHEMICAL BUSINESS NEWSBASE - PRESS RELEASE:
similar ...
Vasogen Announces Full Patient Enrollment in its Pivotal Phase III Trial of Celacade(TM) in Peripheral Arterial Disease
PR Newswire:
similar ...